geldanamycin

tumor protein p53 ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23860250 Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy. 2013 Sep 1
2 22138446 Hsp90 inhibitors sensitise human colon cancer cells to topoisomerase I poisons by depletion of key anti-apoptotic and cell cycle checkpoint proteins. 2012 Feb 1 4
3 22433057 Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells. 2012 Sep 1
4 22865487 18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway. 2012 Nov 1
5 21663398 Geldanamycin analog 17-DMAG limits apoptosis in human peripheral blood cells by inhibition of p53 activation and its interaction with heat-shock protein 90 kDa after exposure to ionizing radiation. 2011 Sep 1
6 20493187 Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells. 2010 Aug 1
7 17982489 Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells. 2008 Apr 10 1
8 18071310 Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1. 2008 May 15 2
9 18504430 Geldanamycin promotes premature mitotic entry and micronucleation in irradiated p53/p21 deficient colon carcinoma cells. 2008 Sep 18 4
10 18630678 [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells]. 2008 Mar 2
11 17268519 Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells. 2007 Apr 3
12 17293044 Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells. 2007 Mar 6 2
13 17666403 CHIP chaperones wild type p53 tumor suppressor protein. 2007 Sep 28 1
14 15613472 Hsp90 is essential for restoring cellular functions of temperature-sensitive p53 mutant protein but not for stabilization and activation of wild-type p53: implications for cancer therapy. 2005 Feb 25 1
15 15284248 Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells. 2004 Oct 8 2
16 15358769 Hsp90 chaperones wild-type p53 tumor suppressor protein. 2004 Nov 19 2
17 12427754 Phosphorylation and hsp90 binding mediate heat shock stabilization of p53. 2003 Jan 17 2
18 12810654 Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of Cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction. 2003 Jun 15 1
19 12843186 The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. 2003 Jul 3
20 11867746 NQO1 stabilizes p53 through a distinct pathway. 2002 Mar 5 2
21 10557093 The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association. 1999 Oct 28 1
22 9488468 The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. 1998 Mar 4
23 9622079 Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations. 1998 Jun 1 1
24 9137531 Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity. 1997 4
25 9190897 Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. 1997 Jun 12 6
26 9417863 Geldanamycin prevents nuclear translocation of mutant p53. 1997 Nov 25 5
27 8599864 Cell-cycle arrest and p53 accumulation induced by geldanamycin in human ovarian tumour cells. 1996 5
28 7675452 Geldanamycin selectively destabilizes and conformationally alters mutated p53. 1995 Sep 7 2